Skip to content

Predictors of Intestinal Anastomosis Leakage, Application of New Predictors and New Scores

Predictors of Intestinal Anastomosis Leakage, Application of New Predictors and New Scores

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04422106
Enrollment
118
Registered
2020-06-09
Start date
2020-06-17
Completion date
2020-12-31
Last updated
2020-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anastomotic Leak

Brief summary

Aim of the work This study aims at; Early detection of disruption and leakage of intestinal anastomotic sites whether small or large intestine by using biochemical markers as predictors and indicators of leakage with application of scoring scale to assess presence or absence of leakage.

Interventions

DIAGNOSTIC_TESTPredictors of intestinal anastomosis leakage, application of new predictors and new scores

Early detection of disruption and leakage of intestinal anastomotic sites whether small or large intestine by using biochemical markers as predictors and indicators of leakage with application of scoring scale to assess presence or absence of leakage.

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Any patient with intestinal or colonic anastomosis either elective or emergent.

Exclusion criteria

* Patients with inflammatory bowel disease will be excluded because this could influence plasma levels of inflammatory biomarkers. * patients using corticosteroids * Patients unfit for anaesthesia, those having collagen diseases or hematological disorders.

Design outcomes

Primary

MeasureTime frameDescription
Early detection and management of intestinal anastomotic leak6 monthsEarly detection of disruption and leakage of intestinal anastomotic sites whether small or large intestine by using biochemical markers as predictors and indicators of leak(Intestinal fatty acid binding protein, Procalcitonin and CRP) with application of scoring scale(Dekker et al 2011) (Dulk et al ., 2013) to assess presence or absence of leakage.

Countries

Egypt

Contacts

Primary ContactMohamed Arnouse
drmhamdy@mans.edu.eg01099222561

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026